| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $15.4M | +53.4% |
| R&D Expense | $261.4M | -18.1% |
| SG&A Expense | $56.7M | -26.0% |
| Operating Income | -$302.7M | +18.7% |
| Income Tax | $0 | — |
| Net Income | -$276.5M | +18.1% |
| EPS (Basic) | -$1.61 | +31.8% |
| EPS (Diluted) | -$1.61 | +31.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $84.0M | -32.4% |
| Current Assets | $578.3M | -28.5% |
| Total Assets | $621.3M | -28.7% |
| Current Liabilities | $25.6M | -49.6% |
| Total Liabilities | $54.3M | -42.0% |
| Stockholders' Equity | $567.1M | -27.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$235.5M | +5.5% |
| Capital Expenditures | $410K | -79.7% |
| Investing Cash Flow | $192.8M | +569.3% |
| Financing Cash Flow | $1.6M | -99.4% |
| Free Cash Flow | -$235.9M | +6.1% |